• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    9.53 Down 0.19(1.95%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:9.72
    Open:9.76
    Bid:5.99 x 100
    Ask:9.50 x 1000
    1y Target Est:11.00
    Beta:-0.69
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:9.34 - 9.76
    52wk Range:2.97 - 13.58
    Volume:384,516
    Avg Vol (3m):621,035
    Market Cap:233.06M
    P/E (ttm):N/A
    EPS (ttm):-1.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TROV

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):802.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.09
    Quarterly EPS Est (Jun-15) :-0.24
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback